CompletedNCT06699940
A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents
Observational studyAges 12–21United StatesAnxiety
Understand this study
Who was this study for?
Listed age limits: 12 years to 21 years.
- Listed locations
- MalvernSee all locations and recruitment
Study information
Study start dateStarted: May 1, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 7,690
- Sponsor
- Neuronetics
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 12 Years to 21 Years
- Official registry ID
- NCT06699940
- Official title
Show the full official title
A Retrospective Registry Study to Evaluate Application of NeuroStar® Advanced Therapy for Depression and Comorbid Anxiety in Adolescents
Recruitment & locations
CompletedMalvern
Questions about this study
Who is behind this study?
The study sponsor is Neuronetics.
Who was this study for?
Listed age limits: 12 years to 21 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me